Analysis of efficacy of DICE (dexamethasone, ifosfamide, cisplatin and etoposide) regimen on recurrent and refractory intermediate and high grade non-Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

Analysis of efficacy of DICE (dexamethasone, ifosfamide, cisplatin and etoposide) regimen on recurrent and refractory intermediate and high grade non-Hodgkin’s lymphoma

Published:2009-02 Issue:1 Volume:6 Page:59-63
ISSN:1672-7118
Container-title:Chinese Journal of Clinical Oncology
language:en
Short-container-title:Chin. J. Clin. Oncol.

Author:

Yang Lei,Song Zhucheng,Xu Xiaohong,Wei Jinzhi,Tan Qinghe,Cong Zhirong,Peng Chunlei

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11805-009-0059-1.pdf

Reference10 articles.

1. Inoue R, Natazuka T, Shimoyama M, et al Feasibility of high-dose chemotherapy without stem cell support as a first-line treatment for non-Hodgkin’s aggressive lymphoma: a pilot study. Leuk Lymphoma 2000; 36: 315–321.

2. Van der Sanden G A, Coebergh J W, Schouten L J, et al Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer 1995; 31: 1822–1829.

3. Messori A, Vaiani M, Trippoli S, et al Survival in patients with intermediate or high grade non-Hodgkin’ s lymphoma meta-analysis of randomized studies comparing third generation regimens with CHOP. Br J Cancer 2001; 84: 303–307.

4. Multani P, White CA, Grillo-Lopez A Non-Hodgkin’ s lymphoma: review of conventional treatments. Curr Pharm Biotechnol 2001; 2: 279–291.

5. Coiffier B Effective immunocheotherapy for aggressive non-Hodgkin’s lymphoma. Semin Oncol 2004; 31: 7–11.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of CCR5 Expression on NK Cells in Iranian Patients With Occult Hepatitis B Infection;Laboratory Medicine;2010-12